Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

“We originally raised about six million from what we call friends and family, and then we also raised two and a ... it was ...

And when I evaluate every patient, I also evaluate their support network. Some women come with strong family support. Some women come alone. Some of those people need more handholding. I want to make ...